New breast cancer vaccine 'promising but not ready for prime time'
2.2.15
Add Comment
New breast cancer vaccine 'promising but not ready for prime time'
They may be baby steps, but researchers at Washington University School of Medicine in St. Louis took a few more of them this week with the publication of a study looking at a potential new breast cancer vaccine. “We've been working on this vaccine for ...
Read more on Fred Hutch News Service
Switzerland's Roche Holding and AC Immune strike U.S. deals
Roche wants to tap FMI's ability to look at the genetics of tumors to better target cancer therapy. And the suitor can use FMI's products to not only help patients but also better measure results ... Meanwhile, in Lausanne, Switzerland, AC Immune said ...
Read more on TheStreet.com
TapImmune plans stock warrant offering
E. in Seattle, describes itself as "an immunotherapy company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease." The company said in a statement that in addition to a $ 1.46 million ...
Read more on Puget Sound Business Journal (Seattle) (blog)
They may be baby steps, but researchers at Washington University School of Medicine in St. Louis took a few more of them this week with the publication of a study looking at a potential new breast cancer vaccine. “We've been working on this vaccine for ...
Read more on Fred Hutch News Service
Switzerland's Roche Holding and AC Immune strike U.S. deals
Roche wants to tap FMI's ability to look at the genetics of tumors to better target cancer therapy. And the suitor can use FMI's products to not only help patients but also better measure results ... Meanwhile, in Lausanne, Switzerland, AC Immune said ...
Read more on TheStreet.com
TapImmune plans stock warrant offering
E. in Seattle, describes itself as "an immunotherapy company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease." The company said in a statement that in addition to a $ 1.46 million ...
Read more on Puget Sound Business Journal (Seattle) (blog)
0 Response to "New breast cancer vaccine 'promising but not ready for prime time'"
Post a Comment